Jakob Loven Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jakob Loven.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jakob Loven. Jakob Loven is Director in ARVINAS INC. ($ARVN) and Director in Kronos Bio, Inc. ($KRON).
Latest Insider Trading Transactions of Jakob Loven
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 20.63 | 19 | 392 | 1,301,537 | 1.3 M to 1.3 M (0.00 %) |
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 20.10 | 21,532 | 432,793 | 1,301,556 | 1.3 M to 1.3 M (-1.63 %) |
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 21.38 | 4,157 | 88,877 | 1,323,088 | 1.3 M to 1.3 M (-0.31 %) |
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 20.25 | 9,847 | 199,402 | 1,327,245 | 1.3 M to 1.3 M (-0.74 %) |
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 21.56 | 7,870 | 169,677 | 1,337,092 | 1.3 M to 1.3 M (-0.59 %) |
Apr 20 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 20.84 | 25,292 | 527,085 | 1,344,962 | 1.4 M to 1.3 M (-1.85 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 21.78 | 24,818 | 540,536 | 1,370,254 | 1.4 M to 1.4 M (-1.78 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 23.10 | 18,938 | 437,468 | 1,395,072 | 1.4 M to 1.4 M (-1.34 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 22.38 | 13,698 | 306,561 | 1,414,010 | 1.4 M to 1.4 M (-0.96 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 25.18 | 1,285 | 32,356 | 1,427,708 | 1.4 M to 1.4 M (-0.09 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 24.40 | 5,738 | 140,007 | 1,428,993 | 1.4 M to 1.4 M (-0.40 %) |
Apr 15 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 23.35 | 9,997 | 233,430 | 1,434,731 | 1.4 M to 1.4 M (-0.69 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.21 | 100 | 2,721 | 1,444,728 | 1.4 M to 1.4 M (-0.01 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 26.27 | 15,728 | 413,175 | 1,444,828 | 1.5 M to 1.4 M (-1.08 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.20 | 21,660 | 589,152 | 1,460,556 | 1.5 M to 1.5 M (-1.46 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.21 | 100 | 2,721 | 1,444,728 | 1.4 M to 1.4 M (-0.01 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.91 | 24,816 | 692,615 | 1,482,216 | 1.5 M to 1.5 M (-1.65 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 26.27 | 15,728 | 413,175 | 1,444,828 | 1.5 M to 1.4 M (-1.08 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.09 | 38,312 | 1,037,872 | 1,507,032 | 1.5 M to 1.5 M (-2.48 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.20 | 21,660 | 589,152 | 1,460,556 | 1.5 M to 1.5 M (-1.46 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.91 | 24,816 | 692,615 | 1,482,216 | 1.5 M to 1.5 M (-1.65 %) |
Apr 12 2021 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Sell | S | 27.09 | 38,312 | 1,037,872 | 1,507,032 | 1.5 M to 1.5 M (-2.48 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Option Exercise | C | 0.00 | 1,304,563 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Buy | C | 16.15 | 169,031 | 2,729,851 | 1,545,344 | 1.4 M to 1.5 M (+12.28 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Buy | C | 0.00 | 1,376,313 | 0 | 1,376,313 | 0 to 1.4 M |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Option Exercise | C | 0.00 | 1,304,563 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Buy | C | 16.15 | 169,031 | 2,729,851 | 1,545,344 | 1.4 M to 1.5 M (+12.28 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Loven Jakob | Director | Buy | C | 0.00 | 1,376,313 | 0 | 1,376,313 | 0 to 1.4 M |
Jun 04 2020 | ARVN | ARVINAS, INC. | Loven Jakob | Director | Option Exercise | A | 33.57 | 12,000 | 402,840 | 12,000 | |
May 28 2019 | ARVN | ARVINAS, INC. | Loven Jakob | Director | Option Exercise | A | 22.06 | 12,923 | 285,081 | 12,923 | |
Oct 03 2018 | ARVN | ARVINAS INC. | Loven Jakob | Director | Option Exercise | C | 0.00 | 4,491,018 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | Loven Jakob | Director | Buy | C | 0.00 | 1,381,851 | 0 | 1,694,351 | 312.5 K to 1.7 M (+442.19 %) |
Oct 03 2018 | ARVN | ARVINAS INC. | Loven Jakob | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
Page: 1